Raphael Pharmaceutical Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
Raphael Pharmaceutical Inc. (RAPH) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $350.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-31.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2025-03-31
- Raphael Pharmaceutical Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $350.00K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|
| 2024-12-31 | $350.00K 10-K · filed 2025-03-31 |